Related Experiment Video
Updated: Jul 10, 2026

10:04
Local Application of Drugs to Study Nicotinic Acetylcholine Receptor Function in Mouse Brain Slices
Published on: October 29, 2012
Identification and functional characterization of brainstem cannabinoid CB2 receptors
Marja D Van Sickle1, Marnie Duncan, Philip J Kingsley
1Institute of Infection, Immunity, and Inflammation and Hotchkiss Brain Institute, Department of Physiology and Biophysics, University of Calgary, Calgary, AB, Canada T2N 4N1.
Summary
The study confirms the presence and function of CB2 receptors in brainstem neurons, offering a novel target for nonpsychotropic therapies by modulating endocannabinoid levels.
Area of Science:
- Neuroscience
- Molecular Biology
- Pharmacology
Background:
- The role of CB2 receptors in the central nervous system (CNS) remains debated.
- Previous research has not definitively established their presence or function in CNS neurons.
Purpose of the Study:
- To investigate the expression and function of CB2 receptors in brainstem neurons.
- To explore the therapeutic potential of targeting CB2 receptors in the CNS.
Main Methods:
- Utilized techniques to detect messenger RNA and protein localization of CB2 receptors.
- Administered a CB2 receptor agonist (2-arachidonoylglycerol) to activate the receptors.
- Examined the effects of elevated endogenous endocannabinoid levels.
Main Results:
- Confirmed the expression of CB2 receptor messenger RNA in brainstem neurons.
- Demonstrated protein localization of CB2 receptors on these neurons.
- Showed that CB2 receptors in the brainstem are activated by a specific agonist and endogenous endocannabinoids.
Conclusions:
- CB2 receptors are functionally present in brainstem neurons.
- These receptors offer an alternative pathway for endocannabinoid action.
- Targeting CB2 receptors presents a potential strategy for nonpsychotropic therapeutic interventions in localized brain areas.
Related Concept Videos
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...
Analgesia and Pain Management
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...

